Healthcare -
Biotechnology - NASDAQ - CH
$ 8.01
-5.76 %
$ 54.7 K
Market Cap
-0.37
P/E
ADXN - COST OF REVENUE
Cost of Revenue ADXN - Addex Therapeutics Ltd
6.94 M
LAST VALUE
-26.44%
2 YEAR CAGR
116.99%
5 YEAR CAGR
54.11%
10 YEAR CAGR